Enfuvirtide (INN), sold under the brand name Fuzeon, is an HIV fusion inhibitor, the first of a class of antiretroviral drugs used in combination therapy...
12 KB (820 words) - 06:03, 18 March 2024
"Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration". Amyloid. 21 (2): 71–5. doi:10.3109/13506129.2013.876984...
62 KB (4,598 words) - 21:08, 10 September 2024
Atazanavir Darunavir Delavirdine Didanosine (ddI) Dolutegravir Efavirenz Enfuvirtide Stavudine (d4T) Etravirine Fosamprenavir Indinavir Lamivudine (3TC) Lopinavir...
26 KB (1,685 words) - 02:08, 21 February 2024
(classification), a disability athletics classification Twenty20, a form of cricket Enfuvirtide, an HIV drug T20 road (Tanzania) German torpedo boat T20 IBM ThinkPad...
1 KB (224 words) - 11:27, 27 April 2024
(sulfadoxine/pyrimethamine), for malaria and toxoplasmosis. Fuzeon (enfuvirtide), for salvage therapy of HIV-1 infection. Gazyva (obinutuzumab), for...
57 KB (5,180 words) - 23:11, 12 September 2024
(single pill) 2015 (Genvoya) Emtricitabine HIV Gilead Sciences NRTI 2003 Enfuvirtide HIV Entry inhibitor 2003 Ensitrelvir COVID-19 Shionogi 3C-like protease...
13 KB (513 words) - 14:31, 4 May 2024
type AKer Semenogelin-1 (SGI) Seminal vesicle amyloidosis ASem1 Proteins S100A8/A9 Prostate cancer none Enfuvirtide Injection-localized amyloidosis AEnf...
60 KB (6,536 words) - 06:48, 29 August 2024
At least one of these entry inhibitors—a biomimetic peptide called Enfuvirtide, or the brand name Fuzeon—has received FDA approval and has been in use...
55 KB (6,733 words) - 06:43, 13 June 2024
To prevent fusion of the virus with the host membrane, enfuvirtide can be used. Enfuvirtide is a peptide drug that must be injected and acts by interacting...
133 KB (16,990 words) - 13:40, 24 August 2024
members of the class were developed Selective COX-2 inhibitor NSAIDs Enfuvirtide, a peptide HIV entry inhibitor Nonbenzodiazepines like zolpidem and zopiclone...
44 KB (5,022 words) - 20:19, 7 September 2024
Dalbavancin, bacterial infections, IV Daptomycin, bacterial infections, IV Enfuvirtide, HIV, subcutaneous injection Oritavancin, bacterial infections, IV Teicoplanin...
61 KB (6,549 words) - 21:38, 28 August 2024
PMID 22908191. Greenberg ML, Cammack N (August 2004). "Resistance to enfuvirtide, the first HIV fusion inhibitor". The Journal of Antimicrobial Chemotherapy...
34 KB (3,860 words) - 04:15, 25 March 2024
Lenacapavir (LEN) Entry/fusion inhibitors (Discovery and development) gp41 (Enfuvirtide (ENF, T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†)...
15 KB (1,230 words) - 02:38, 16 July 2024
large-scale piloting of one of the first synthesized peptide drugs, enfuvirtide, began in the 1990s, when market demand adjusted the relative prices...
54 KB (6,100 words) - 16:21, 3 August 2024
Lenacapavir (LEN) Entry/fusion inhibitors (Discovery and development) gp41 (Enfuvirtide (ENF, T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†)...
28 KB (2,975 words) - 02:18, 11 August 2024
enestebol (INN) enfenamic acid (INN) enfilcon A (USAN) enflurane (INN) enfuvirtide (USAN) englitazone (INN) eniclobrate (INN) enilconazole (INN) enilospirone...
10 KB (468 words) - 20:41, 27 August 2024
synthesis. Thus, for the production of Roche's anti-AIDS drug Fuzeon (enfuvirtide), three fragments of 10–12 amino acids are first made by solid-phase...
99 KB (12,113 words) - 10:55, 22 February 2024
referred to as a "chemokine receptor antagonist" or a "CCR5 inhibitor." Enfuvirtide binds to gp41 and interferes with its ability to approximate the two...
9 KB (1,095 words) - 03:47, 25 December 2023
potential target for therapeutic intervention and inhibitory peptides. Enfuvirtide (also known as T-20) is a 36-residue alpha-peptide fusion inhibitor drug...
14 KB (1,709 words) - 03:20, 12 March 2024
is unlikely to promote resistance to itself. Investigators found that enfuvirtide-resistant and ibalizumab-resistant HIV envelopes remained susceptible...
15 KB (1,293 words) - 07:10, 18 July 2024
assist in fusion with the host cell. Fusion inhibitor drugs such as enfuvirtide block the fusion process by binding to gp41. The Mouse Mammary Tumor...
17 KB (2,253 words) - 14:23, 3 December 2023
Bernard Lessard, Serge Dufresne, and Richard Lalonde. "Switch from enfuvirtide to raltegravir in patients with undetectable viral load: efficacy and...
10 KB (679 words) - 20:47, 5 July 2024
[citation needed] VIR-576 mechanism of action differs from other drugs. Enfuvirtide (also known as T-20), for example, is a fusion inhibitor which binds...
17 KB (1,628 words) - 22:17, 28 November 2023
J05AX02 Lysozyme J05AX05 Inosine pranobex J05AX06 Pleconaril J05AX07 Enfuvirtide J05AX09 Maraviroc J05AX10 Maribavir J05AX12 Dolutegravir J05AX13 Umifenovir...
6 KB (538 words) - 04:59, 18 December 2023
neuropeptide Y 82785-45-3 C200H312N62O57S6 psalmotoxin C202H298N50O64 enfuvirtide 159519-65-0 C205H339N59O63S corticorelin 79804-71-0 C207H308N56O58S seractide...
47 KB (16 words) - 08:43, 18 August 2022
Lenacapavir (LEN) Entry/fusion inhibitors (Discovery and development) gp41 (Enfuvirtide (ENF, T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†)...
3 KB (338 words) - 13:45, 27 July 2023
peptide T20/DP178 is a licensed anti-retrovirus agent (pentafuside) termed Enfuvirtide which acts at the level of HIV-target cell fusion and is used clinically...
30 KB (3,909 words) - 08:46, 30 April 2024